ANDI(0.0021) HUGE DD $$ >>Awareness campaign is starting on ANDI & Kinsley Street Investors Group that run HBRM& CHRI prices is going to run ANDI price UP
check this from last Monday PR
Steve Weiss, CEO of Kinsley Street Investors Group and Director of Corporate Acquisitions for China-based China Health Resources Inc (OTCBB: CHRI), said, "We are very excited to work with Andiamo Corporation. Mr. Secor has done a great job of defining the company within the exploding smartphone App sector and we feel ANDI is tremendously undervalued. Bringing value to undervalued companies is what we do best."
PS: Kinsley Street Investors Group is responsible for the HBRM&CHRI price run from these levels to pennies
Andiamo Corporation (PINKSHEETS: ANDI), subsidiary ActionApp Corporation, a prolific mobile App development company, announces its plan to launch an aggressive Investors Awareness Campaign to continue throughout 2012. Strategies and programs are designed to increase mass market awareness of the Company among individual investors, institutions, and analysts.
As its first major step in Investor Relations, ANDI is pleased to announce that Kinsley Street Investors Group has been hired to provide the strategic investor relations.
"Kinsley brings a significant level of experience and the ability to generate increased exposure for ANDI within the professional investment community that will be an asset as we continue to grow and expand our business," commented Dustin Secor, CEO of ANDI.
Kinsley will work closely with ANDI to develop an ongoing comprehensive investor relations message to solidify investor support and to develop, maintain and broaden their investor base through a unified and focused investor awareness strategy.
Under the agreement, Kinsley will assist the Company with media awareness, shareholder communications, introducing the Company to potential investors and assisting with promotional road shows.
"We are pleased to have Kinsley on board to enhance the visibility of our company in the investment community. They bring excellent experience to our team and will be a great benefit in communicating our message to the investing public," Secor further commented.
Steve Weiss, CEO of Kinsley Street Investors Group and Director of Corporate Acquisitions for China-based China Health Resources Inc (OTCBB: CHRI), said, "We are very excited to work with Andiamo Corporation. Mr. Secor has done a great job of defining the company within the exploding smartphone App sector and we feel ANDI is tremendously undervalued. Bringing value to undervalued companies is what we do best."
About Andiamo Corporation:
Operating through its subsidiary, ActionApp Corporation, which is currently expanding their popular and profitable inventory of apps in rapid fashion across Apple and Android Markets. Starting with just 26 Apps a year ago, ActionApp currently has over 150 approved apps with another 350+ under current development. ActionApp has a short term goal to bring their total to 500 apps in their portfolio, with 1000 Apps set for a longer term goal. ActionApps has exceeded 16 million downloads.
www.action-app.com
Please see our Safe Harbor Statement: www.action-app.com/statement/
Andiamo Corporation
Investor Relations
>>>>>>>>>>>>>> ANDI Harbor Madness game selling on Apple Store this Month >>
Viper Networks, Inc. (Pink Sheets:VPER), is pleased to announce that the chief executives of both companies, Aequitas Energy, Inc. and Viper Networks respectively, are slated to review final agreement documents tomorrow Saturday May 26th, in hopes of reaching final agreement for the Company to acquire thirty percent (30%) of the energy reseller company based in New Haven, Connecticut.
Final contract documents were forwarded to Aequitas executives by Viper Networks attorneys late Friday afternoon. After contact was made by each party early this evening, both company presidents agreed to review final contract terms on Saturday in hopes of concluding this important agreement before the Memorial holiday on Monday.
Please note the Company is displaying a 'temporary' corporate site at www.vipernetworks.com.
2) Imaging Diagnostic Systems, Inc. (IDSI) is a development stage medical technology company. The Company is engaged in the development and testing of a Computed Tomography Laser Breast Imaging System for detecting breast cancer (CT Laser Mammography (CTLM). As of June 30, 2010, IDSI was in the process of commercializing the CTLM in certain international markets where approvals to market have been secured although CTLM is not yet approved for sale in the United States. During the fiscal year ended June 30, 2010, the Company had no revenues from its operations. The CTLM system is a CT-like scanner, but its energy source is a laser beam and not ionizing x-radiation such as is used in conventional x-ray mammography or CT scanners. IDSI’s Laser Imager for Lab Animals (LILA) program is an optical helical micro-CT scanner in a third-generation configuration.
As of November 2010, IDSI has submitted a 510(k) application to the FDA. With this submission, the company moves forward in the process of seeking marketing clearance for its innovative breast imaging device, the CTLM system. The Company intends to pursue a rigorous clinical program to discover and commercialize the envisioned applications.
7) The company has received CE Marking, CMDCAS (Canada), Canadian License, UL listing, ISO 13485 certification, China SFDA and FDA export certification, enabling sales in international markets.
10) Imaging Diagnostic Signs Shimadzu Medical to Market Its CTLM(R) Laser Breast Imaging Device in Australia, New Zealand and the Pacific Islands
FORT LAUDERDALE, FL, May 14, 2012 (MARKETWIRE via COMTEX) -- Imaging Diagnostic Systems, Inc. (OTCBB: IMDS), a pioneer in laser breast imaging, announced today that it has signed a distribution agreement with Shimadzu Medical to market and sell its Computed Tomography Laser Mammography (CTLM(R)) System in Australia, New Zealand and the Pacific Islands.
"This strategic move follows in line with our vision to be in the forefront of innovative technologies that will further enhance our business. The Directors of Shimadzu Corporation unanimously agreed that the CTLM(R) system could heighten our image in the breast imaging realm. IDSI has developed a high quality innovative breast imaging product that will expand our product range. Shimadzu is well positioned to provide ongoing sales, service and support for the CTLM given our history and expertise in the medical device arena. We are excited to make this innovative technology available to women in Australia, New Zealand and the Pacific Islands," commented Nick Mascoulis, General Manager/Shimadzu Medical Systems (Oceania) P/L.
Shimadzu Medical Systems (Oceania) Pty Ltd is an Australasian subsidiary of Shimadzu Corporation, Kyoto, Japan. Shimadzu's goal is to support a healthy, comfortable living for all people. They have strived to contribute to people's health and well-being since their inception in 1875. Shimadzu focuses on the development of "molecular imaging technology" to enable detection of subtle symptoms before the onset of full-blown diseases.
Linda Grable, CEO of Imaging Diagnostic Systems, Inc., states, "IDSI is very excited to appoint Shimadzu Corporation, a leader of global technologies, as the distributor in Australia, New Zealand and the Pacific Islands. We are eager to work with Shimadzu to make CTLM(R) available to women in that part of the globe."
11) Imaging Diagnostic's Non-Invasive CTLM(R) Laser Breast Imaging Device Will Soon Be Available to Women in Kuwait
FORT LAUDERDALE, FL, May 22, 2012 (MARKETWIRE via COMTEX) -- Imaging Diagnostic Systems, Inc. IMDS 0.00% , a pioneer in laser breast imaging, announced today that it has signed a distribution agreement with Mareen Group to market and sell its Computed Tomography Laser Mammography (CTLM(R)) System in Kuwait.
"Mareen Group is honored to present the CTLM(R) to the women of Kuwait. We are eager to support the imaging needs of patients through this dignified and innovative laser breast imaging modality," commented Ahmad Abdulrahman, General Manager of Mareen Group.
Mareen Group is a Medical & Pharmaceutical distribution company well established and based in Kuwait. They have been in operation since 1998, proudly providing various medical and healthcare institutions within Kuwait and the surrounding areas with advanced medical equipment and pharmaceuticals from across the globe. The philosophy of Mareen Group has always been to build close ties with their customers by supporting their every need with prompt professional service and support.
Imaging Diagnostic's CEO, Linda Grable, states, "IDSI is delighted to assign Mareen Group, a well established medical company in Kuwait, as our new distributor. The women in Kuwait will hopefully benefit from CTLM(R)'s unique and discrete breast imaging process to aid in the diagnosis and management of breast abnormalities. We are enthusiastic to work with Mareen Group to make the CTLM(R), a non-invasive alternative, accessible to women in Kuwait."
IMDS is very undervalued solid company, Read, check the links..make your own decision
WITH FDA PENDING NEWS THIS WILL GO UP MULTI-CENTS LEVEL, IMO.
News 
Market Data 
Discover 
